Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Nadav Eiron Joins Crusoe as Senior Vice President of Cloud Engineering
06:00am, Wednesday, 03'rd Apr 2024
SAN FRANCISCO--(BUSINESS WIRE)--Crusoe Energy Systems LLC (“Crusoe”) announced today that Nadav Eiron has joined the company as a Senior Vice President to lead the Cloud Engineering team in Crusoe
Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
06:00am, Wednesday, 03'rd Apr 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Here's Why Insulet (PODD) is a Strong Growth Stock
10:46am, Tuesday, 02'nd Apr 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Medical Product Stocks to Buy Amid Industry Challenges
09:37am, Tuesday, 02'nd Apr 2024
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poi
Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?
10:56am, Thursday, 28'th Mar 2024
The consensus price target hints at a 38.9% upside potential for Insulet (PODD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
5 Stocks to Buy on the Dip to Gain From the Wall Street Rally
01:01pm, Friday, 22'nd Mar 2024
We have narrowed our search to five large-cap stocks with attractive valuations. These are TWLO, ZS, NEE, AWK and PODD.
3 Strong Stocks Down at Least 30% to Buy Now
08:00am, Thursday, 21'st Mar 2024
Three S&P 500 stocks worth considering as buy-and-hold investments that are down at least 30% from their highs even as the market trades at records.
Here's Why You Should Buy Insulet (PODD) Stock Right Now
09:25am, Monday, 18'th Mar 2024
Investors remain confident in the Insulet (PODD) stock due to the huge success of Omnipod 5.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:46am, Thursday, 14'th Mar 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are These 5 Undervalued Stocks Ready to Break Out?
09:11am, Friday, 08'th Mar 2024
Albemarle Corp. NYSE: ALB, Ionis Pharmaceuticals Inc. NASDAQ: IONS, Insulet Corp. NASDAQ: PODD, Hess Corp. NYSE: HES and Wynn Resorts Ltd. NASDAQ: WYNN are among undervalued stocks that beat analysts
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will present new
Is It Time to Buy the S&P 500's 3 Worst-Performing February Stocks?
05:30am, Monday, 04'th Mar 2024
Lots of investors fear the advent of weight loss drugs could take a toll on insulin pump maker Insulet, by curbing diabetes. Cable television company Charter Communications is bumping into a new headw
Insulet (PODD) Q4 Earnings, Revenues Top Mark, Margins Expand
10:01am, Wednesday, 28'th Feb 2024
In the fourth quarter, Insulet (PODD) achieves the milestone of 425,000 estimated active global customers using Omnipod products.
Down -15.31% in 4 Weeks, Here's Why You Should You Buy the Dip in Insulet (PODD)
10:36am, Tuesday, 27'th Feb 2024
Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising e
Insulet (PODD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
07:01pm, Thursday, 22'nd Feb 2024
Although the revenue and EPS for Insulet (PODD) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Stre
